Suppr超能文献

口腔白斑非手术治疗综述

A review of the nonsurgical treatment of oral leukoplakia.

作者信息

Ribeiro Adriana Spinola, Salles Patrícia Ribeiro, da Silva Tarcília Aparecida, Mesquita Ricardo Alves

机构信息

Department of Oral Surgery, Medicine and Pathology, Dental School, Federal University of Minas Gerais, CEP 31.270-901, Belo Horizonte, Minas Gerais, Brazil.

出版信息

Int J Dent. 2010;2010:186018. doi: 10.1155/2010/186018. Epub 2010 Feb 23.

Abstract

The aim of this paper was to assess the nonsurgical treatment of oral leukoplakia (OL). A medline search from 1983 to 2009 was conducted. The topical or systemic nonsurgical treatments or combination of both was reviewed. The primary outcomes of interest were clinical resolution, malignant transformation, follow-up, and recurrence of OL. Studies showed a rate higher than 50% of clinical resolution with photodynamic therapy, beta-carotene, lycopene, or vitamin A. Few studies reported rates of recurrence from 5 to 67% and of malignant transformation from 8 to 23%. There is a lack of randomized clinical trials that assess the effectiveness of nonsurgical treatment of OL. At this time, randomized controlled trials for nonsurgical treatment of OL demonstrate no evidence of effective treatment in preventing malignant transformation and recurrence. It reinforces that even after clinical resolution, OL should be regularly followed.

摘要

本文旨在评估口腔白斑(OL)的非手术治疗。对1983年至2009年的医学文献数据库进行了检索。回顾了局部或全身非手术治疗或两者联合治疗。主要关注的结果是临床缓解、恶变、随访及OL复发。研究表明,光动力疗法、β-胡萝卜素、番茄红素或维生素A的临床缓解率高于50%。少数研究报告复发率为5%至67%,恶变率为8%至23%。缺乏评估OL非手术治疗有效性的随机临床试验。目前,OL非手术治疗的随机对照试验表明,没有证据显示在预防恶变和复发方面有有效治疗方法。这进一步强调,即使临床缓解后,OL也应定期随访。

相似文献

1
A review of the nonsurgical treatment of oral leukoplakia.
Int J Dent. 2010;2010:186018. doi: 10.1155/2010/186018. Epub 2010 Feb 23.
2
Interventions for treating oral leukoplakia.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001829. doi: 10.1002/14651858.CD001829.pub3.
3
Interventions for treating oral leukoplakia.
Cochrane Database Syst Rev. 2004(3):CD001829. doi: 10.1002/14651858.CD001829.pub2.
4
Interventions for treating oral leukoplakia.
Cochrane Database Syst Rev. 2001(4):CD001829. doi: 10.1002/14651858.CD001829.
6
Chemoprevention in oral leukoplakia: challenges and current landscape.
Front Oral Health. 2023 May 24;4:1191347. doi: 10.3389/froh.2023.1191347. eCollection 2023.
7
Although leukoplakia responds to some treatments relapses and adverse effects are common.
Evid Based Dent. 2005;6(1):15-6. doi: 10.1038/sj.ebd.6400311.
8
Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
Int J Cancer. 2015 Apr 1;136(7):1708-17. doi: 10.1002/ijc.29156. Epub 2014 Sep 5.
10
A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail.
Natl J Maxillofac Surg. 2023 Sep-Dec;14(3):413-419. doi: 10.4103/njms.njms_25_23. Epub 2023 Nov 10.

引用本文的文献

1
Evaluation of Clinical Outcomes and Recurrence After Surgical Excision of Oral Leukoplakia: A Prospective Cohort Study.
Cureus. 2024 Oct 16;16(10):e71593. doi: 10.7759/cureus.71593. eCollection 2024 Oct.
2
Longitudinal Study of Oral Precancerous Lesions: Transformation Rate and Predictive Markers for Malignancy.
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2555-S2557. doi: 10.4103/jpbs.jpbs_301_24. Epub 2024 Jul 31.
3
Cryotherapy for oral potentially malignant disorders.
Bioinformation. 2023 Dec 31;19(13):1377-1382. doi: 10.6026/973206300191377. eCollection 2023.
4
Management of zygomatic fractures using different surgical approaches.
Bioinformation. 2023 Dec 31;19(13):1371-1376. doi: 10.6026/973206300191371. eCollection 2023.
5
Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
Fam Med Community Health. 2023 Dec 17;11(Suppl 1):e002397. doi: 10.1136/fmch-2023-002397.
7
Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.
Front Pharmacol. 2022 Apr 20;13:825266. doi: 10.3389/fphar.2022.825266. eCollection 2022.
8
Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications.
Nutrients. 2022 Jan 26;14(3):531. doi: 10.3390/nu14030531.
9

本文引用的文献

1
Mass spectrometry approaches for vitamin E research.
Biochem Soc Trans. 2008 Oct;36(Pt 5):1066-70. doi: 10.1042/BST0361066.
2
Protective effect of lycopene in cardiovascular disease.
Eur Rev Med Pharmacol Sci. 2008 May-Jun;12(3):183-90.
3
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management.
Oral Oncol. 2009 Apr-May;45(4-5):317-23. doi: 10.1016/j.oraloncology.2008.05.016. Epub 2008 Jul 31.
4
Management of potentially malignant disorders: evidence and critique.
J Oral Pathol Med. 2008 Feb;37(2):63-9. doi: 10.1111/j.1600-0714.2007.00575.x.
5
Natural history of potentially malignant oral lesions and conditions: an overview of the literature.
J Oral Pathol Med. 2008 Jan;37(1):1-10. doi: 10.1111/j.1600-0714.2007.00579.x.
6
Nomenclature and classification of potentially malignant disorders of the oral mucosa.
J Oral Pathol Med. 2007 Nov;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x.
7
Photodynamic therapy in dentistry.
J Dent Res. 2007 Aug;86(8):694-707. doi: 10.1177/154405910708600803.
8
Fenretinide activity in retinoid-resistant oral leukoplakia.
Clin Cancer Res. 2006 May 15;12(10):3109-14. doi: 10.1158/1078-0432.CCR-05-2636.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验